Global Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Regional Outlook and Forecast, 2024 - 2031

The Global Psychiatric Digital Biomarkers Market size is expected to reach $2.78 billion by 2031, rising at a market growth of 24.1% CAGR during the forecast period.

Europe's increasing awareness of the importance of real-time monitoring and predictive analytics in mental health further drives the market’s growth in the region. Therefore, the Europe segment acquired 23% revenue share in the market in 2023. Favorable regulatory environments and public-private partnerships have supported the adoption of digital biomarkers across the region. Countries like Germany, the UK, and France are key contributors, with their investments in AI-driven healthcare and emphasis on personalized mental health care.

Integrating psychiatric digital biomarkers with artificial intelligence (AI) and machine learning (ML) technologies has amplified their potential. These technologies analyze immense quantities of patient data to predict outcomes and identify patterns, thereby assisting clinicians in the development of more precise diagnoses and the optimization of treatment plans. Thus, the shift toward personalized medicine, powered by psychiatric digital biomarkers, not only empowers clinicians but also fosters patient trust and engagement as individuals receive care that is precisely aligned with their unique mental health needs. Additionally, In the private sector, startups and established firms drive innovation in mental health technology. The surge in investment also supports research and development, particularly in integrating digital biomarkers into clinical trials. Pharmaceutical companies like Novartis and Pfizer are collaborating with tech firms to utilize wearable and app-based biomarkers for real-time assessment of psychiatric drug efficacy. Therefore, these factors will drive the growth of the market.

However, the reliance on cutting-edge technologies like artificial intelligence (AI), machine learning, and mobile devices in psychiatric digital biomarkers creates significant accessibility challenges. While these technologies can potentially revolutionize mental health care, they also unintentionally exclude populations with limited technological access or low digital literacy. Rural or economically disadvantaged areas, for example, often lack the infrastructure to support these advanced tools, such as reliable internet connectivity or modern smartphones. Hence, these factors may hamper the growth of the market.

End User Outlook

By end-users, the market is divided into integrated device manufacturers (IDMs), semiconductor fabless companies, semiconductor test equipment manufacturers, and semiconductor outsourced assembly & test houses (OSATs). The semiconductor fabless companies segment garnered 26% revenue share in the market in 2023. Semiconductor fabless companies are driven by the need to ensure design efficiency and manufacturability, which are critical to maintaining their competitive position in the market.

Type Outlook

Based on type, the market is classified into wearable, mobile based applications, sensors, and others. The wearable segment garnered 38% revenue share in the market in 2023. The wearable segment is propelled by its capacity to continuously monitor physiological and behavioral parameters, including physical activity, sleep patterns, and pulse rate, which are critical for the evaluation of mental health conditions. The convenience and integration of wearable devices with sophisticated analytics platforms, such as fitness trackers and smartwatches, have made them a popular choice among patients and healthcare providers.

Clinical Practice Outlook

On the basis of clinical practice, the market is divided into diagnostic psychiatric digital biomarkers, monitoring psychiatric digital biomarkers, predictive & prognostic psychiatric digital biomarkers, and others. The monitoring psychiatric digital biomarkers segment recorded 27% revenue share in the market in 2023. The growing emphasis on continuous mental health management and personalized care propels this segment. These biomarkers enable real-time tracking of a patient’s mental state, providing valuable data for assessing treatment efficacy and disease progression. The accessibility of monitoring solutions has been expanded by the rising usage of telehealth services and the integration of mobile applications.

End Use Outlook

By end use, the market is segmented into healthcare companies, healthcare providers, payers, and others. The healthcare companies segment witnessed 48% revenue share in the market in 2023. These companies make substantial investments in research and development, utilizing sophisticated technologies such as AI, machine learning, and big data analytics to develop state-of-the-art mental health diagnostics and management solutions. Strategic partnerships with technology firms, academic institutions, and healthcare providers further enhance their ability to develop robust, scalable, and clinically validated products.

Free Valuable Insights: Global Psychiatric Digital Biomarkers Market size to reach USD 2.78 Billion by 2031

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 53% revenue share in the market in 2023. The region’s high adoption of innovative tools like wearables and mobile applications is bolstered by increasing awareness of mental health issues and strong policy support. Government initiatives promoting digital health, alongside robust funding for mental health research, have further accelerated the growth of psychiatric digital biomarkers in North America. The region's capacity to dominate the market is also improved by the integration of AI and machine learning into healthcare systems.

Psychiatric Digital Biomarkers Market Report Coverage

Report Attribute	Details
Market size value in 2023	USD 517.47 Million
Market size forecast in 2031	USD 2.78 Billion
Base Year	2023
Historical Period	2020 to 2022
Forecast Period	2024 to 2031
Revenue Growth Rate	CAGR of 24.1% from 2024 to 2031
Number of Pages	231
Tables	379
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered	Type, Clinical Practice, End Use, Region
Country scope	North America (US, Canada, Mexico, and Rest of North America) Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe) Asia Pacific (Japan, China, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific) LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included	Canary Speech, Inc, Sonde Health, Inc. (Puretech Health Plc), Koneksa Health Inc., Empatica Inc., VivoSense, Inc., IXICO Plc, Neurotrack Technologies, Inc., Winterlight Labs, Aural Analytics, Inc. (Linus Health)

List of Key Companies Profiled

• Canary Speech, Inc
• Sonde Health, Inc. (Puretech Health Plc)
• Koneksa Health Inc.
• Empatica Inc.
• VivoSense, Inc.
• IXICO Plc
• Neurotrack Technologies, Inc.
• Winterlight Labs
• Aural Analytics, Inc. (Linus Health)

Psychiatric Digital Biomarkers Market Report Segmentation

By Type

• Wearable
• Mobile based Applications
• Sensors
• Other Type

By Clinical Practice

• Diagnostic Psychiatric Digital Biomarkers
• Monitoring Psychiatric Digital Biomarkers
• Predictive and Prognostic Psychiatric Digital Biomarkers
• Other Clinical Practice

By End Use

• Healthcare Companies
• Healthcare Providers
• Payers
• Other End Use

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Psychiatric Digital Biomarkers Market, by Type
1.4.2 Global Psychiatric Digital Biomarkers Market, by Clinical Practice
1.4.3 Global Psychiatric Digital Biomarkers Market, by End Use
1.4.4 Global Psychiatric Digital Biomarkers Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Global Psychiatric Digital Biomarkers Market by Type
4.1 Global Wearable Market by Region
4.2 Global Mobile based Applications Market by Region
4.3 Global Sensors Market by Region
4.4 Global Other Type Market by Region

Chapter 5. Global Psychiatric Digital Biomarkers Market by Clinical Practice
5.1 Global Diagnostic Psychiatric Digital Biomarkers Market by Region
5.2 Global Monitoring Psychiatric Digital Biomarkers Market by Region
5.3 Global Predictive and Prognostic Psychiatric Digital Biomarkers Market by Region
5.4 Global Other Clinical Practice Market by Region

Chapter 6. Global Psychiatric Digital Biomarkers Market by End Use
6.1 Global Healthcare Companies Market by Region
6.2 Global Healthcare Providers Market by Region
6.3 Global Payers Market by Region
6.4 Global Other End Use Market by Region

Chapter 7. Global Psychiatric Digital Biomarkers Market by Region
7.1 North America Psychiatric Digital Biomarkers Market
7.1.1 North America Psychiatric Digital Biomarkers Market by Type
7.1.1.1 North America Wearable Market by Country
7.1.1.2 North America Mobile based Applications Market by Country
7.1.1.3 North America Sensors Market by Country
7.1.1.4 North America Other Type Market by Country
7.1.2 North America Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.2.1 North America Diagnostic Psychiatric Digital Biomarkers Market by Country
7.1.2.2 North America Monitoring Psychiatric Digital Biomarkers Market by Country
7.1.2.3 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
7.1.2.4 North America Other Clinical Practice Market by Country
7.1.3 North America Psychiatric Digital Biomarkers Market by End Use
7.1.3.1 North America Healthcare Companies Market by Country
7.1.3.2 North America Healthcare Providers Market by Country
7.1.3.3 North America Payers Market by Country
7.1.3.4 North America Other End Use Market by Country
7.1.4 North America Psychiatric Digital Biomarkers Market by Country
7.1.4.1 US Psychiatric Digital Biomarkers Market
7.1.4.1.1 US Psychiatric Digital Biomarkers Market by Type
7.1.4.1.2 US Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.4.1.3 US Psychiatric Digital Biomarkers Market by End Use
7.1.4.2 Canada Psychiatric Digital Biomarkers Market
7.1.4.2.1 Canada Psychiatric Digital Biomarkers Market by Type
7.1.4.2.2 Canada Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.4.2.3 Canada Psychiatric Digital Biomarkers Market by End Use
7.1.4.3 Mexico Psychiatric Digital Biomarkers Market
7.1.4.3.1 Mexico Psychiatric Digital Biomarkers Market by Type
7.1.4.3.2 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.4.3.3 Mexico Psychiatric Digital Biomarkers Market by End Use
7.1.4.4 Rest of North America Psychiatric Digital Biomarkers Market
7.1.4.4.1 Rest of North America Psychiatric Digital Biomarkers Market by Type
7.1.4.4.2 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.4.4.3 Rest of North America Psychiatric Digital Biomarkers Market by End Use
7.2 Europe Psychiatric Digital Biomarkers Market
7.2.1 Europe Psychiatric Digital Biomarkers Market by Type
7.2.1.1 Europe Wearable Market by Country
7.2.1.2 Europe Mobile based Applications Market by Country
7.2.1.3 Europe Sensors Market by Country
7.2.1.4 Europe Other Type Market by Country
7.2.2 Europe Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.2.1 Europe Diagnostic Psychiatric Digital Biomarkers Market by Country
7.2.2.2 Europe Monitoring Psychiatric Digital Biomarkers Market by Country
7.2.2.3 Europe Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
7.2.2.4 Europe Other Clinical Practice Market by Country
7.2.3 Europe Psychiatric Digital Biomarkers Market by End Use
7.2.3.1 Europe Healthcare Companies Market by Country
7.2.3.2 Europe Healthcare Providers Market by Country
7.2.3.3 Europe Payers Market by Country
7.2.3.4 Europe Other End Use Market by Country
7.2.4 Europe Psychiatric Digital Biomarkers Market by Country
7.2.4.1 Germany Psychiatric Digital Biomarkers Market
7.2.4.1.1 Germany Psychiatric Digital Biomarkers Market by Type
7.2.4.1.2 Germany Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.1.3 Germany Psychiatric Digital Biomarkers Market by End Use
7.2.4.2 UK Psychiatric Digital Biomarkers Market
7.2.4.2.1 UK Psychiatric Digital Biomarkers Market by Type
7.2.4.2.2 UK Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.2.3 UK Psychiatric Digital Biomarkers Market by End Use
7.2.4.3 France Psychiatric Digital Biomarkers Market
7.2.4.3.1 France Psychiatric Digital Biomarkers Market by Type
7.2.4.3.2 France Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.3.3 France Psychiatric Digital Biomarkers Market by End Use
7.2.4.4 Russia Psychiatric Digital Biomarkers Market
7.2.4.4.1 Russia Psychiatric Digital Biomarkers Market by Type
7.2.4.4.2 Russia Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.4.3 Russia Psychiatric Digital Biomarkers Market by End Use
7.2.4.5 Spain Psychiatric Digital Biomarkers Market
7.2.4.5.1 Spain Psychiatric Digital Biomarkers Market by Type
7.2.4.5.2 Spain Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.5.3 Spain Psychiatric Digital Biomarkers Market by End Use
7.2.4.6 Italy Psychiatric Digital Biomarkers Market
7.2.4.6.1 Italy Psychiatric Digital Biomarkers Market by Type
7.2.4.6.2 Italy Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.6.3 Italy Psychiatric Digital Biomarkers Market by End Use
7.2.4.7 Rest of Europe Psychiatric Digital Biomarkers Market
7.2.4.7.1 Rest of Europe Psychiatric Digital Biomarkers Market by Type
7.2.4.7.2 Rest of Europe Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.4.7.3 Rest of Europe Psychiatric Digital Biomarkers Market by End Use
7.3 Asia Pacific Psychiatric Digital Biomarkers Market
7.3.1 Asia Pacific Psychiatric Digital Biomarkers Market by Type
7.3.1.1 Asia Pacific Wearable Market by Country
7.3.1.2 Asia Pacific Mobile based Applications Market by Country
7.3.1.3 Asia Pacific Sensors Market by Country
7.3.1.4 Asia Pacific Other Type Market by Country
7.3.2 Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.2.1 Asia Pacific Diagnostic Psychiatric Digital Biomarkers Market by Country
7.3.2.2 Asia Pacific Monitoring Psychiatric Digital Biomarkers Market by Country
7.3.2.3 Asia Pacific Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
7.3.2.4 Asia Pacific Other Clinical Practice Market by Country
7.3.3 Asia Pacific Psychiatric Digital Biomarkers Market by End Use
7.3.3.1 Asia Pacific Healthcare Companies Market by Country
7.3.3.2 Asia Pacific Healthcare Providers Market by Country
7.3.3.3 Asia Pacific Payers Market by Country
7.3.3.4 Asia Pacific Other End Use Market by Country
7.3.4 Asia Pacific Psychiatric Digital Biomarkers Market by Country
7.3.4.1 China Psychiatric Digital Biomarkers Market
7.3.4.1.1 China Psychiatric Digital Biomarkers Market by Type
7.3.4.1.2 China Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.1.3 China Psychiatric Digital Biomarkers Market by End Use
7.3.4.2 Japan Psychiatric Digital Biomarkers Market
7.3.4.2.1 Japan Psychiatric Digital Biomarkers Market by Type
7.3.4.2.2 Japan Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.2.3 Japan Psychiatric Digital Biomarkers Market by End Use
7.3.4.3 India Psychiatric Digital Biomarkers Market
7.3.4.3.1 India Psychiatric Digital Biomarkers Market by Type
7.3.4.3.2 India Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.3.3 India Psychiatric Digital Biomarkers Market by End Use
7.3.4.4 South Korea Psychiatric Digital Biomarkers Market
7.3.4.4.1 South Korea Psychiatric Digital Biomarkers Market by Type
7.3.4.4.2 South Korea Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.4.3 South Korea Psychiatric Digital Biomarkers Market by End Use
7.3.4.5 Singapore Psychiatric Digital Biomarkers Market
7.3.4.5.1 Singapore Psychiatric Digital Biomarkers Market by Type
7.3.4.5.2 Singapore Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.5.3 Singapore Psychiatric Digital Biomarkers Market by End Use
7.3.4.6 Malaysia Psychiatric Digital Biomarkers Market
7.3.4.6.1 Malaysia Psychiatric Digital Biomarkers Market by Type
7.3.4.6.2 Malaysia Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.6.3 Malaysia Psychiatric Digital Biomarkers Market by End Use
7.3.4.7 Rest of Asia Pacific Psychiatric Digital Biomarkers Market
7.3.4.7.1 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Type
7.3.4.7.2 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.4.7.3 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by End Use
7.4 LAMEA Psychiatric Digital Biomarkers Market
7.4.1 LAMEA Psychiatric Digital Biomarkers Market by Type
7.4.1.1 LAMEA Wearable Market by Country
7.4.1.2 LAMEA Mobile based Applications Market by Country
7.4.1.3 LAMEA Sensors Market by Country
7.4.1.4 LAMEA Other Type Market by Country
7.4.2 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.2.1 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country
7.4.2.2 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country
7.4.2.3 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
7.4.2.4 LAMEA Other Clinical Practice Market by Country
7.4.3 LAMEA Psychiatric Digital Biomarkers Market by End Use
7.4.3.1 LAMEA Healthcare Companies Market by Country
7.4.3.2 LAMEA Healthcare Providers Market by Country
7.4.3.3 LAMEA Payers Market by Country
7.4.3.4 LAMEA Other End Use Market by Country
7.4.4 LAMEA Psychiatric Digital Biomarkers Market by Country
7.4.4.1 Brazil Psychiatric Digital Biomarkers Market
7.4.4.1.1 Brazil Psychiatric Digital Biomarkers Market by Type
7.4.4.1.2 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.1.3 Brazil Psychiatric Digital Biomarkers Market by End Use
7.4.4.2 Argentina Psychiatric Digital Biomarkers Market
7.4.4.2.1 Argentina Psychiatric Digital Biomarkers Market by Type
7.4.4.2.2 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.2.3 Argentina Psychiatric Digital Biomarkers Market by End Use
7.4.4.3 UAE Psychiatric Digital Biomarkers Market
7.4.4.3.1 UAE Psychiatric Digital Biomarkers Market by Type
7.4.4.3.2 UAE Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.3.3 UAE Psychiatric Digital Biomarkers Market by End Use
7.4.4.4 Saudi Arabia Psychiatric Digital Biomarkers Market
7.4.4.4.1 Saudi Arabia Psychiatric Digital Biomarkers Market by Type
7.4.4.4.2 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.4.3 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use
7.4.4.5 South Africa Psychiatric Digital Biomarkers Market
7.4.4.5.1 South Africa Psychiatric Digital Biomarkers Market by Type
7.4.4.5.2 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.5.3 South Africa Psychiatric Digital Biomarkers Market by End Use
7.4.4.6 Nigeria Psychiatric Digital Biomarkers Market
7.4.4.6.1 Nigeria Psychiatric Digital Biomarkers Market by Type
7.4.4.6.2 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.6.3 Nigeria Psychiatric Digital Biomarkers Market by End Use
7.4.4.7 Rest of LAMEA Psychiatric Digital Biomarkers Market
7.4.4.7.1 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type
7.4.4.7.2 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.4.7.3 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use

Chapter 8. Company Profiles
8.1 Canary Speech, Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Sonde Health, Inc. (Puretech Health Plc)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.2.5 SWOT Analysis
8.3 Koneksa Health Inc.
8.3.1 Company Overview
8.4 Empatica Inc.
8.4.1 Company Overview
8.5 VivoSense, Inc.
8.5.1 Company Overview
8.6 IXICO plc
8.6.1 Company Overview
8.7 Neurotrack Technologies, Inc.
8.7.1 Company Overview
8.8 WinterLight Labs
8.8.1 Company Overview
8.9 Aural Analytics, Inc. (Linus Health)
8.9.1 Company Overview

Chapter 9. Winning Imperatives of Psychiatric Digital Biomarkers Market

TABLE 1 Global Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 Global Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 Global Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 4 Global Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 5 Global Wearable Market by Region, 2020 - 2023, USD Million
TABLE 6 Global Wearable Market by Region, 2024 - 2031, USD Million
TABLE 7 Global Mobile based Applications Market by Region, 2020 - 2023, USD Million
TABLE 8 Global Mobile based Applications Market by Region, 2024 - 2031, USD Million
TABLE 9 Global Sensors Market by Region, 2020 - 2023, USD Million
TABLE 10 Global Sensors Market by Region, 2024 - 2031, USD Million
TABLE 11 Global Other Type Market by Region, 2020 - 2023, USD Million
TABLE 12 Global Other Type Market by Region, 2024 - 2031, USD Million
TABLE 13 Global Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 14 Global Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 15 Global Diagnostic Psychiatric Digital Biomarkers Market by Region, 2020 - 2023, USD Million
TABLE 16 Global Diagnostic Psychiatric Digital Biomarkers Market by Region, 2024 - 2031, USD Million
TABLE 17 Global Monitoring Psychiatric Digital Biomarkers Market by Region, 2020 - 2023, USD Million
TABLE 18 Global Monitoring Psychiatric Digital Biomarkers Market by Region, 2024 - 2031, USD Million
TABLE 19 Global Predictive and Prognostic Psychiatric Digital Biomarkers Market by Region, 2020 - 2023, USD Million
TABLE 20 Global Predictive and Prognostic Psychiatric Digital Biomarkers Market by Region, 2024 - 2031, USD Million
TABLE 21 Global Other Clinical Practice Market by Region, 2020 - 2023, USD Million
TABLE 22 Global Other Clinical Practice Market by Region, 2024 - 2031, USD Million
TABLE 23 Global Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 24 Global Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 25 Global Healthcare Companies Market by Region, 2020 - 2023, USD Million
TABLE 26 Global Healthcare Companies Market by Region, 2024 - 2031, USD Million
TABLE 27 Global Healthcare Providers Market by Region, 2020 - 2023, USD Million
TABLE 28 Global Healthcare Providers Market by Region, 2024 - 2031, USD Million
TABLE 29 Global Payers Market by Region, 2020 - 2023, USD Million
TABLE 30 Global Payers Market by Region, 2024 - 2031, USD Million
TABLE 31 Global Other End Use Market by Region, 2020 - 2023, USD Million
TABLE 32 Global Other End Use Market by Region, 2024 - 2031, USD Million
TABLE 33 Global Psychiatric Digital Biomarkers Market by Region, 2020 - 2023, USD Million
TABLE 34 Global Psychiatric Digital Biomarkers Market by Region, 2024 - 2031, USD Million
TABLE 35 North America Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 36 North America Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 37 North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 38 North America Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 39 North America Wearable Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Wearable Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Sensors Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Sensors Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Other Type Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Other Type Market by Country, 2024 - 2031, USD Million
TABLE 47 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 48 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 49 North America Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 50 North America Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 51 North America Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 52 North America Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 53 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 54 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 55 North America Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 56 North America Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 57 North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 58 North America Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 59 North America Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 60 North America Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 61 North America Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 62 North America Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 63 North America Payers Market by Country, 2020 - 2023, USD Million
TABLE 64 North America Payers Market by Country, 2024 - 2031, USD Million
TABLE 65 North America Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 66 North America Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 67 North America Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 68 North America Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 69 US Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 70 US Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 71 US Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 72 US Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 73 US Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 74 US Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 75 US Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 76 US Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 77 Canada Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 78 Canada Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 79 Canada Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 80 Canada Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 81 Canada Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 82 Canada Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 83 Canada Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 84 Canada Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 85 Mexico Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 86 Mexico Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 87 Mexico Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 88 Mexico Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 89 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 90 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 91 Mexico Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 92 Mexico Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 93 Rest of North America Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 94 Rest of North America Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 95 Rest of North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 96 Rest of North America Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 97 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 98 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 99 Rest of North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 100 Rest of North America Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 101 Europe Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 102 Europe Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 103 Europe Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 104 Europe Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 105 Europe Wearable Market by Country, 2020 - 2023, USD Million
TABLE 106 Europe Wearable Market by Country, 2024 - 2031, USD Million
TABLE 107 Europe Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 108 Europe Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 109 Europe Sensors Market by Country, 2020 - 2023, USD Million
TABLE 110 Europe Sensors Market by Country, 2024 - 2031, USD Million
TABLE 111 Europe Other Type Market by Country, 2020 - 2023, USD Million
TABLE 112 Europe Other Type Market by Country, 2024 - 2031, USD Million
TABLE 113 Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 114 Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 115 Europe Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 116 Europe Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 117 Europe Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 118 Europe Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 119 Europe Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 120 Europe Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 121 Europe Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 122 Europe Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 123 Europe Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 124 Europe Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 125 Europe Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 126 Europe Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 127 Europe Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 128 Europe Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 129 Europe Payers Market by Country, 2020 - 2023, USD Million
TABLE 130 Europe Payers Market by Country, 2024 - 2031, USD Million
TABLE 131 Europe Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 132 Europe Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 133 Europe Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 134 Europe Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 135 Germany Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 136 Germany Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 137 Germany Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 138 Germany Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 139 Germany Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 140 Germany Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 141 Germany Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 142 Germany Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 143 UK Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 144 UK Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 145 UK Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 146 UK Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 147 UK Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 148 UK Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 149 UK Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 150 UK Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 151 France Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 152 France Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 153 France Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 154 France Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 155 France Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 156 France Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 157 France Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 158 France Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 159 Russia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 160 Russia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 161 Russia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 162 Russia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 163 Russia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 164 Russia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 165 Russia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 166 Russia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 167 Spain Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 168 Spain Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 169 Spain Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 170 Spain Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 171 Spain Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 172 Spain Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 173 Spain Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 174 Spain Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 175 Italy Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 176 Italy Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 177 Italy Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 178 Italy Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 179 Italy Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 180 Italy Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 181 Italy Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 182 Italy Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 183 Rest of Europe Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 184 Rest of Europe Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 185 Rest of Europe Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 186 Rest of Europe Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 187 Rest of Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 188 Rest of Europe Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 189 Rest of Europe Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 190 Rest of Europe Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 191 Asia Pacific Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 192 Asia Pacific Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 193 Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 194 Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 195 Asia Pacific Wearable Market by Country, 2020 - 2023, USD Million
TABLE 196 Asia Pacific Wearable Market by Country, 2024 - 2031, USD Million
TABLE 197 Asia Pacific Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 198 Asia Pacific Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 199 Asia Pacific Sensors Market by Country, 2020 - 2023, USD Million
TABLE 200 Asia Pacific Sensors Market by Country, 2024 - 2031, USD Million
TABLE 201 Asia Pacific Other Type Market by Country, 2020 - 2023, USD Million
TABLE 202 Asia Pacific Other Type Market by Country, 2024 - 2031, USD Million
TABLE 203 Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 204 Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 205 Asia Pacific Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 206 Asia Pacific Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 207 Asia Pacific Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 208 Asia Pacific Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 209 Asia Pacific Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 210 Asia Pacific Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 211 Asia Pacific Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 212 Asia Pacific Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 213 Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 214 Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 215 Asia Pacific Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 216 Asia Pacific Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 217 Asia Pacific Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 218 Asia Pacific Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 219 Asia Pacific Payers Market by Country, 2020 - 2023, USD Million
TABLE 220 Asia Pacific Payers Market by Country, 2024 - 2031, USD Million
TABLE 221 Asia Pacific Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 222 Asia Pacific Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 223 Asia Pacific Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 224 Asia Pacific Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 225 China Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 226 China Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 227 China Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 228 China Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 229 China Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 230 China Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 231 China Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 232 China Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 233 Japan Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 234 Japan Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 235 Japan Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 236 Japan Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 237 Japan Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 238 Japan Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 239 Japan Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 240 Japan Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 241 India Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 242 India Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 243 India Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 244 India Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 245 India Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 246 India Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 247 India Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 248 India Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 249 South Korea Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 250 South Korea Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 251 South Korea Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 252 South Korea Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 253 South Korea Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 254 South Korea Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 255 South Korea Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 256 South Korea Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 257 Singapore Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 258 Singapore Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 259 Singapore Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 260 Singapore Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 261 Singapore Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 262 Singapore Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 263 Singapore Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 264 Singapore Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 265 Malaysia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 266 Malaysia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 267 Malaysia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 268 Malaysia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 269 Malaysia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 270 Malaysia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 271 Malaysia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 272 Malaysia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 273 Rest of Asia Pacific Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 274 Rest of Asia Pacific Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 275 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 276 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 277 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 278 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 279 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 280 Rest of Asia Pacific Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 281 LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 282 LAMEA Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 283 LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 284 LAMEA Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 285 LAMEA Wearable Market by Country, 2020 - 2023, USD Million
TABLE 286 LAMEA Wearable Market by Country, 2024 - 2031, USD Million
TABLE 287 LAMEA Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 288 LAMEA Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 289 LAMEA Sensors Market by Country, 2020 - 2023, USD Million
TABLE 290 LAMEA Sensors Market by Country, 2024 - 2031, USD Million
TABLE 291 LAMEA Other Type Market by Country, 2020 - 2023, USD Million
TABLE 292 LAMEA Other Type Market by Country, 2024 - 2031, USD Million
TABLE 293 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 294 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 295 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 296 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 297 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 298 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 299 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 300 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 301 LAMEA Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 302 LAMEA Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 303 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 304 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 305 LAMEA Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 306 LAMEA Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 307 LAMEA Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 308 LAMEA Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 309 LAMEA Payers Market by Country, 2020 - 2023, USD Million
TABLE 310 LAMEA Payers Market by Country, 2024 - 2031, USD Million
TABLE 311 LAMEA Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 312 LAMEA Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 313 LAMEA Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 314 LAMEA Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 315 Brazil Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 316 Brazil Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 317 Brazil Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 318 Brazil Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 319 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 320 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 321 Brazil Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 322 Brazil Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 323 Argentina Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 324 Argentina Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 325 Argentina Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 326 Argentina Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 327 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 328 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 329 Argentina Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 330 Argentina Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 331 UAE Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 332 UAE Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 333 UAE Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 334 UAE Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 335 UAE Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 336 UAE Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 337 UAE Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 338 UAE Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 339 Saudi Arabia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 340 Saudi Arabia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 341 Saudi Arabia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 342 Saudi Arabia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 343 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 344 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 345 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 346 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 347 South Africa Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 348 South Africa Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 349 South Africa Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 350 South Africa Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 351 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 352 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 353 South Africa Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 354 South Africa Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 355 Nigeria Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 356 Nigeria Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 357 Nigeria Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 358 Nigeria Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 359 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 360 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 361 Nigeria Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 362 Nigeria Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 363 Rest of LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 364 Rest of LAMEA Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 365 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 366 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 367 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 368 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 369 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 370 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 371 Key Information – Canary Speech, Inc.
TABLE 372 Key Information – Sonde Health, Inc.
TABLE 373 Key Information – Koneksa Health Inc.
TABLE 374 Key Information – Empatica Inc.
TABLE 375 Key Information – VivoSense, Inc.
TABLE 376 Key Information – IXICO plc
TABLE 377 Key Information – Neurotrack Technologies, Inc.
TABLE 378 Key Information – WinterLight Labs
TABLE 379 Key Information – Aural Analytics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Psychiatric Digital Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Psychiatric Digital Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – Psychiatric Digital Biomarkers Market
FIG 5 Global Psychiatric Digital Biomarkers Market share by Type, 2023
FIG 6 Global Psychiatric Digital Biomarkers Market share by Type, 2031
FIG 7 Global Psychiatric Digital Biomarkers Market by Type, 2020 - 2031, USD Million
FIG 8 Global Psychiatric Digital Biomarkers Market share by Clinical Practice, 2023
FIG 9 Global Psychiatric Digital Biomarkers Market share by Clinical Practice, 2031
FIG 10 Global Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2031, USD Million
FIG 11 Global Psychiatric Digital Biomarkers Market share by End Use, 2023
FIG 12 Global Psychiatric Digital Biomarkers Market share by End Use, 2031
FIG 13 Global Psychiatric Digital Biomarkers Market by End Use, 2020 - 2031, USD Million
FIG 14 Global Psychiatric Digital Biomarkers Market share by Region, 2023
FIG 15 Global Psychiatric Digital Biomarkers Market share by Region, 2031
FIG 16 Global Psychiatric Digital Biomarkers Market by Region, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Canary Speech, Inc.
FIG 18 Recent strategies and developments: Sonde Health, Inc.
FIG 19 SWOT Analysis: Sonde Health, Inc.